Evidence map›Paper›PMID 38418660›Full record

ArticleScientific reports2024

Production of iron enriched Saccharomyces boulardii: impact of process variables.

Kiyana Tafazzoli, Mehrdad Ghavami, Kianoush Khosravi-Darani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Bioconversion of FePharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kiyana TafazzoliDepartment of Food Science and Technology, Science and Research Branch, Islamic Azad University, Tehran, Iran.ORCID 0000-0002-5998-6914
Mehrdad GhavamiDepartment of Food Science and Technology, Science and Research Branch, Islamic Azad University, Tehran, Iran.ORCID 0000-0002-3635-6776
Kianoush Khosravi-DaraniDepartment of Food Technology Research, Faculty of Nutrition Sciences and Food Technology/National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran. k.khosravi@sbmu.ac.ir.ORCID 0000-0002-0269-6385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About half of the 1.62 billion cases of anemia are because of poor diet and iron deficiency. Currently, the use of iron-enriched yeasts can be used as the most effective and possible way to prevent and treat anemia due to the ability of biotransformation of mineral compounds into the organic form. In this research, for the first time, Saccharomyces (S.) boulardii was used for iron enrichment with the aim that the probiotic properties of yeast provide a potential iron supplement besides improving the bioavailability of iron. Also, due to its higher resistance than other Saccharomyces strains against stresses, it can protect iron against processing temperatures and stomach acidic-enzymatic conditions. So, the effect of three important variables, including concentration of iron, molasses and KH

Indexed as

AnemiaProbioticsSaccharomycesSaccharomyces boulardiiIronSaccharomyces cerevisiaeIronBioaccumulationBox-BehnkenDesign of experimentsEnriched yeastFeYProbiotic yeastProcess variableSaccharomyces boulardii

Identifiers

PMID38418660
PMCPMC10902395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.